维普期刊资源整合服务平台（V6.5）

82篇 您的检索式：作者名="Pazdur"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Nover chemotherapeutic agents for gastrointestinal cancers显示文摘	Royce ME Pazdur R	1999	Curr Opin Oncol1999，11，4：	1
2	End points and United States Food and Drug Administration approval of oncology drugs显示文摘	Johnson JR Williams G Pazdur R	2003	J Clin Oncol2003，21，7：	1
3	Docetaxel显示文摘	Cortes J E Pazdur R	1995	J Clin Oncol1995，13，10：	1
4	Novel Chemotherapeutic agents for gastrointestinal cancers显示文摘	Pazdur R	1999	Curr Opin Oncol1999，11，4：	1
5	End points and United States Food and Drug Administration approval of oncology drugs 显示文摘	Johnson JR Williams G Pazdur R	2003	J Clin Oncol2003，21，7：	1
6	End Points and United States Food and Drug Administration Approved of Oncology Drug显示文摘	Johhnson J R Williams G Pazdur R	2003	J Clin Oncol2003，21，：	1
7	Response to Neoadjuvant Chemotherapy Best Predicts Survival After Curative Resection of Gastric Cancer显示文摘	Andrew M. Lowy Paul F. Mansfield Steven D. Leach Richard Pazdur Pamela Dumas Jaffer A. Ajani	1999	Annals of Surgery1999，，3：	1
8	Docetaxel 显示文摘	Cortes JE Pazdur R	1995	J Clin Oncol1995，13，10：	1
9	FDA approval summary: vorinostat for treatment of ad- vanced primary cutaneous T-cell lymphoma 显示文摘	Mann BS Johnson JR Cohen MH Justice R Pazdur R	2007	Oncolo- gist2007，12，10：	1
10	FDA drug approval summary:gefitinib(ZD1839)(Iressa) tablets显示文摘	Cohen M H Williams G A Sridhara R Chen G Pazdur R	2003	Oncologist2003，8，：	1
11	A phase Ⅲ trial of xeloda (capecitabine) in previously untreated advanced / metastatic colorectal cancer显示文摘	Cox JV Pazdur R Thibault A	1999	Proc Am Soc Clin Oncol1999，18，1：	1
12	Medical Management of Colorectal Careinomas显示文摘	Versehraegen C F Pazdur R	1994	Tumori1994，80，1：	1
13	Novel chemotherapeutic agents for gastrointestinal cancers 显示文摘	Royce ME Pazdur R	1999	Cult Opin Oncol1999，11，4：	1
14	Phase Ⅰ trial of uracil-tegafurplus oral leucovorin:14-day schedule显示文摘	Pazdur R Lassere Y Diaz-Canton E	1997	Invest New Drugs1997，15，2：	1
15	Enrollment of elderly patients in clin- ical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration 显示文摘	Talarico L Chen G Pazdur R	2004	J Clin Oncol2004，22，22：	1
16	Food and Drug Administration drug approval summary:temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme显示文摘	COHEN M H JOHNSON J R PAZDUR R	2005	Clin Cancer Res2005，11，191：	1
17	Novel chemotherapeutic agents for gastrointestinal cancer 显示文摘	Royc ME Pazdur R	1999	Curr Opin Oncol1999，11，4：	1
18	Endpoints for assessing drug activity in clini-cal trials显示文摘	Pazdur R	2008	Oncologist2008，13，2：	1
19	Comparison of 5-fluorouracil pharmocokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil显示文摘	Ho DH Pazdur R Covington W	1998	Clin Cancer Res1998，4，9：	1
20	Phase Ⅰ trial of Taxotere:five day schedule显示文摘	Pazdur R Newman RA Newman BM	1992	J Natl Cancer Inst1992，84，23：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示